@article{article, title  = {{Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Springer Verlag }},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/116243 https://doi.org/10.1007/s40273-016-0386-z }},

 year = {{2016}},

 month = {{7}},

 author = {{Squires H and Stevenson M and Simpson E and Harvey R and Stevens J}},

 doi = {{10.1007/s40273-016-0386-z}},

 volume = {{34}},

 journal = {{PharmacoEconomics}},

 issue = {{7}},

 pages = {{673-680}},

 note = {{Accessed on 2024/12/21}}}